Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2/3 1Phase 2 1

Status

Unknown 9Completed 4Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Rectal Neoplasms 6Colorectal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 2Mesothelioma, Malignant 2Colonic Neoplasms 2Stomach Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × raltitrexed × Clear all
NCT04761185 2026-02-25

Raltitrexed in HIPEC

Fudan University

Phase 1 Completed
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01348412 2018-07-16

HEARTO

Centre Georges Francois Leclerc

Phase 2 Completed
31 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00002828 2013-06-21

Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00234429 2007-12-18

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

AstraZeneca

Phase 2/3 Completed
74 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡